6-6

 

Distribution of number of hogs (left scale) and pounds of pork product (right scale) with various melamine tissue concentrations,

 

130

6-7

 

A decision tree for a testing-with-intervention decision involving infant formula and hog feed,

 

134

6-8

 

Potential outcomes of a decision to test infant formula but not animal feed, assuming a test without error, and interventions if the test result is positive,

 

135

6-9

 

Tree for the decision to test formula but not feed, including uncertainty about test accuracy,

 

136

TABLES

2-1

 

Summary of Attributes and Metrics,

 

33

3-1

 

Risk Attributes for Mitigation-Selection Decision for Biologics,

 

49

3-2

 

Estimated Numbers and Rates of Deaths and Illnesses from Rotavirus Disease in the Absence of Vaccination,

 

55

3-3

 

Example Calculation of Estimated Number of Deaths and Illnesses from Rotavirus Disease and RRV-TV-Induced Intussusceptions for Option to Leave the Vaccine on Market (Based on Median Estimates of all Factors),

 

59

4-1

 

Risk Attributes for Targeting Decision for Foods,

 

69

4-2

 

Agents Linked to Shrimp-Associated Outbreaks and Cases in the United States, 2001-2005,

 

79

5-1

 

Risk Attributes for Strategic-Investment Decision for Medical Devices,

 

96

5-2

 

Mortality Estimates,

 

99

6-1

 

Risk Attributes for Targeting Decision that Spans Food and Drug Administration Centers,

 

116

6-2

 

Formula Consumption by Age,

 

118

6-3

 

Estimated Dose for Infants Consuming Formula with Melamine at 100 ppm in Dry Formula,

 

120

6-4

 

Estimates of Mortality and Morbidity from Melamine Contamination in Infant Formula for the Hypothesized Dose-Response Relationship Incorporating Uncertainty in Exposure and Dose,

 

124

6-5

 

Concentration of Hog Production in 2006,

 

128

6-6

 

Melamine Doses to Humans Who Consume Pork with Various Melamine Tissue Concentrations,

 

131



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement